Young Diane C. 4
4 · Celldex Therapeutics, Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Young Diane C.
SVP, CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2021-11-12$10.38/sh+4,600$47,748→ 6,715 total - Sale
Common Stock
2021-11-12$42.94/sh−4,600$197,529→ 2,115 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2021-11-12−4,600→ 67,400 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (4,600 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.6400 to $43.2000 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.